Amgen presents its E-Health projects to the members of the IDIS Foundation Board of Trustees

Representatives of the AMGEN biotechnology have presented the members of the Innovation Committee of the IDIS Foundation (Institute for the Development and Integration of Health) the different e-health projects that are being carried out in order to improve the efficiency of services and innovation of the health system and, therefore, optimize management in hospitals and the well-being of patients.

Teresa Martín, Regional Manager of Institutional Relations at Amgen and Esther García-Buscallá, Access Innovation & Partnership Lead at Amgen, have explained that “e-health has become an essential tool for comprehensive monitoring of patients, contributing to its development to provide citizens with health care, regardless of their personal condition or geographical location, facilitating mobility and allowing the choice of appropriate health resources ”.

The biotech is working on holistic and flexible projects, adapted to the needs of the hospital and patients, ranging from videoconferencing, agenda tracking, medical reports, messaging or educational platforms, among others.

As an example, CARDIOplan is a clinical support tool developed by AMGEN to assist cardiologists in monitoring their heart disease patients and involving them in their cardiac treatment and rehabilitation. On the one hand, the patient is empowered with greater control of their own disease and, on the other, it gives value to cardiologists by reducing the workload (reducing waiting lists, monitoring objectives, patient adherence, etc. ).

On the other hand, during the session, #ProtectUrLife, a primary prevention initiative that supports health centers and hospitals and seeks to promote healthy aging raising awareness about the importance of taking care of cardiovascular and bone health from the age of 65.

In this sense, as a consequence of the coronavirus pandemic and the new habits of social distancing, “the digital tool is used to support the elderly population virtually”And was thus exposed to the members of the IDIS Foundation board of trustees.